NovoCare Pharmacy Explained: How Self-Pay Wegovy Works in 2026

NovoCare Pharmacy is Novo Nordisk’s own direct-to-patient pharmacy, and it’s the route to buy brand Wegovy at a self-pay cash price instead of the roughly $1,349 list price. As of 2026, new patients pay $199 a month for the first two fills on the starter doses, then $349 a month for the Wegovy pen at standard maintenance doses, or $399 a month for the higher-dose Wegovy HD. The Wegovy pill runs $149 a month at its lower doses. If you’ve seen older write-ups quoting $499, that figure is out of date; the price was cut in late 2025. This is a cash-pay option built for people whose insurance doesn’t cover Wegovy.

Here’s how the program works, what it costs, and who it’s actually a good fit for.

What NovoCare Pharmacy is

NovoCare is the affordability hub Novo Nordisk runs for its own medicines, and NovoCare Pharmacy is the mail-order arm that ships brand Wegovy directly to self-pay patients. Your prescriber sends the prescription to NovoCare Pharmacy, or you enroll in the savings offer and take it to a participating pharmacy. The point of the program is to give people without Wegovy coverage a predictable cash price for the authentic, FDA-approved product, rather than the full list price at a retail counter.

What Wegovy costs through NovoCare in 2026

The pricing depends on whether you’re using the pen or the pill, and where you are in your titration. A month is defined as a box of four pens for the injection, or a bottle of 30 tablets for the pill.

A couple of details to know. The $199 introductory price applies to the first two monthly fills for new patients on the 0.25 mg and 0.5 mg starter doses, then it steps up to the standard $349. The pill’s $149 price covers the 1.5 mg and 4 mg doses, with the 4 mg at that price through late summer 2026 before it rises, and higher pill doses cost more. To get any of these prices, you fill through NovoCare Pharmacy or use the savings offer.

Who NovoCare is for, and who it isn’t

NovoCare’s cash price is aimed squarely at people who don’t have insurance coverage for Wegovy, whether that’s because they’re uninsured or because their plan carves out weight-loss drugs. For that group, $349 a month beats the roughly $1,349 list price by a wide margin.

It’s worth knowing what NovoCare is not. If you have commercial insurance that covers Wegovy, the manufacturer savings offer can take your cost to as little as $25 a month, which is lower than the NovoCare cash price, so the savings card route usually wins for that group. And if you’re on Medicare, Medicaid, or other government coverage, you’re excluded from both the $25 savings card and, in most cases, the cash self-pay program structured around it. Medicare beneficiaries have a separate new pathway: eligible Part D members can access Wegovy for $50 a month through the Medicare GLP-1 Bridge starting July 1, 2026.

How NovoCare compares to other Wegovy routes

Consider a scenario where someone without Wegovy coverage is weighing how to pay. Here’s the rough hierarchy in 2026: a covered commercial plan plus the savings card is cheapest at around $25, eligible Medicare members land at $50 through the Bridge, NovoCare self-pay sits at $349 to $399, and the retail list price tops out near $1,349. The big jump is between any program price and the list price, which is why so few people should ever pay full freight. Our breakdown of the Wegovy cash price goes deeper on those numbers, and if you’re starting from scratch, how to get Wegovy online covers the prescription side.

The clinical track record is part of what makes Wegovy worth this kind of cost planning. In the STEP 8 trial (Rubino et al., JAMA 2022), once-weekly semaglutide 2.4 mg produced significantly greater weight loss over 68 weeks than daily liraglutide, alongside better improvements in several cardiometabolic markers.

NovoCare versus a cash-pay telehealth program

NovoCare gets you brand Wegovy at a manufacturer cash price, which is a solid deal if you specifically want the branded pen or pill and you don’t have coverage. The main alternative for cash-pay patients is a telehealth program built around the same active molecule. For a side-by-side of the lowest-cost legitimate options, our look at the cheapest telehealth GLP-1 program compares them on price, what’s included, and the fine print to watch.

TrimRx is a cash-pay telehealth program that connects you with licensed providers for physician-prescribed semaglutide and tirzepatide, with monthly pricing across the program’s medications running from $179 to $1,579 depending on the medication and plan. It bundles the provider visit and shipping into a flat monthly structure, with no insurance and no prior authorization. To see whether it’s a fit, the free assessment quiz takes a few minutes and routes your information to a licensed provider for review.

This article is for general educational purposes and isn’t medical advice. Drug pricing and manufacturer programs change frequently, so verify current NovoCare and Wegovy pricing with Novo Nordisk, your insurer, and your prescriber before making decisions.